Pre-Open Stock Movers 04/30: (LAUR) (WDC) (TEAM) Higher; (MVIS) (ARDX) (TWTR) Lower (more...)

April 30, 2021 9:28 AM EDT
Get Alerts MVIS Hot Sheet
Price: $14.10 +0.71%

Overall Analyst Rating:
    NEUTRAL (= Flat)

Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Today's Pre-Open Stock Movers:

Microvision (NASDAQ: MVIS) 21.9% LOWER; reported Q1 EPS of ($0.04), $0.02 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $479 thousand versus the consensus estimate of $600 thousand.

Ardelyx, Inc. (Nasdaq: ARDX) 17.3% LOWER; announced that the Prescription Drug User Fee Act (PDUFA) date for tenapanor for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis has been extended by three months.

Twitter (NYSE: TWTR) 12% LOWER; reported Q1 EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.03 billion. Twitter sees Q2 2021 revenue of $980-1090 million, versus the consensus of $1060 million.

Cirrus Logic, Inc. (NASDAQ: CRUS) 11.3% LOWER; reported Q4 EPS of $0.66, $0.05 worse than the analyst estimate of $0.71. Revenue for the quarter came in at $293.5 million versus the consensus estimate of $302.47 million. Cirrus Logic, Inc. sees Q1 2022 revenue of $240-280 million, versus the consensus of $312.36 million.

Laureate Education (NASDAQ: LAUR) 7.4% HIGHER; Says DOJ Investigation Has Concluded

Skyworks Solutions (NASDAQ: SWKS) 7.3% LOWER; reported Q2 EPS of $2.37, $0.02 better than the analyst estimate of $2.35. Revenue for the quarter came in at $1.17 billion versus the consensus estimate of $1.15 billion. Skyworks Solutions sees Q3 2021 EPS of $2.13, versus the consensus of $2.10. Skyworks Solutions sees Q3 2021 revenue of $1.075-1.125 billion, versus the consensus of $1.07 billion.

Limelight Networks (NASDAQ: LLNW) 5.8% LOWER; reported Q1 EPS of ($0.09), $0.06 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $51.2 million versus the consensus estimate of $54.17 million. Limelight Networks sees Q2 2021 EPS of ($0.15)-($0.05), versus the consensus of ($0.05). Limelight Networks sees Q2 2021 revenue of $220-230 million, versus the consensus of $225.38 million.

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS) 5.7% HIGHER; announced that the United Kingdoms Medicines and Healthcare Regulatory Agency (MHRA) has approved Ogluo injection for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.

DexCom (NASDAQ: DXCM) 5.6% LOWER; reported Q1 EPS of $0.33, $0.03 better than the analyst estimate of $0.30. Revenue for the quarter came in at $505 million versus the consensus estimate of $484.23 million. DexCom sees FY2021 revenue of $2.26-2.36 billion, versus the consensus of $2.32 billion.

Western Digital (NASDAQ: WDC) 5% HIGHER; reported Q3 EPS of $1.02, $0.34 better than the analyst estimate of $0.68. Revenue for the quarter came in at $4.1 billion versus the consensus estimate of $3.97 billion. Expecting fiscal fourth quarter 2021 revenue to be in the range of $4.40 billion to $4.60 billion with non-GAAP EPS in the range of $1.30 to $1.60.

Atlassian (NASDAQ: TEAM) 5% HIGHER; reported Q3 EPS of $0.63, $0.34 better than the analyst estimate of $0.29. Revenue for the quarter came in at $568.7 million versus the consensus estimate of $533.73 million.

Emergent BioSolutions (NYSE: EBS) 5% LOWER; reported Q1 EPS of $1.53, $0.41 better than the analyst estimate of $1.12. Revenue for the quarter came in at $343 million versus the consensus estimate of $358.47 million. Emergent BioSolutions sees Q2 2021 revenue of $370-430 million, versus the consensus of $502.3 million.

Green Plains Renewable Energy (NASDAQ: GPRE) 5% HIGHER; Credit Suisse initiates coverage with an Outperform rating and a price target of $44.00.

AstraZeneca (NASDAQ: AZN) 3.7% HIGHER; The company reported Q1 sales of $7.32 billion to top the $6.94 billion expected from market analysts. AZN said that it benefited from robust sales of its best-selling lung cancer drug Tagrisso, which generated $1.15 billion in sales. Core earnings per share (EPS) were reported at $1.63 to exceed the consensus of $1.48.

Amazon (NASDAQ: AMZN) 3.7% HIGHER; reported Q1 EPS of $15.79, $6.25 better than the analyst estimate of $9.54. Revenue for the quarter came in at $108.5 billion versus the consensus estimate of $104.46 billion. Amazon sees Q2 2021 revenue of $110-116 billion, versus the consensus of $108.68 billion.

1-800-FLOWERS.COM (NASDAQ: FLWS) 2.5% HIGHER; DA Davidson upgraded from Neutral to Buy with a price target of $57.00 (from $30.00).

eHealth (NASDAQ: EHTH) 2.2% HIGHER; reported Q1 EPS of $0.36, $0.29 better than the analyst estimate of $0.07. Revenue for the quarter came in at $134.2 million versus the consensus estimate of $111.34 million. eHealth sees FY2021 EPS of $2.77-$3.26, versus the consensus of $2.82. eHealth sees FY2021 revenue of $660-700 million, versus the consensus of $682.98 million.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Credit Suisse, D.A. Davidson, Twitter, Earnings, Pre-Open Losers, Pre-Open Winners, Pre Market Movers, PDUFA